ACET.NASDAQAdicet Bio, INC

Form 4: Adicet Bio CEO's Tax Withholding Disclosure

Sentiment:

Statement of Changes in Beneficial Ownership


Adicet Bio's President and CEO, Schor Chen, reported a transaction involving shares withheld by the company to cover tax obligations related to restricted stock unit vesting.

Summary

  • Schor Chen, President & CEO and Director of Adicet Bio, Inc. (ACET), reported a transaction on January 24, 2026.
  • The transaction involved the withholding of 1,755 shares of Common Stock by Adicet Bio to satisfy tax obligations in connection with the vesting of restricted stock units.
  • The shares were valued at $8.44 per share for the purpose of tax withholding.
  • Following this transaction, Schor Chen directly beneficially owns 6,820 shares of Common Stock.
  • Additionally, 2,716 shares are indirectly held by The I. Schor IRRV Trust, and 3,339 shares are indirectly held by The C. Schor IRRV Trust.
  • All reported share numbers reflect a 1-for-16 reverse stock split effected by Adicet Bio on December 30, 2025.

Sentiment

Score: 5

Explanation: The filing reports a routine tax withholding transaction related to RSU vesting, which is a neutral event and does not indicate a change in company fundamentals or management's outlook.

Future Outlook

NA

Industry Context

This filing is a standard insider transaction disclosure and does not provide information related to broader industry trends or competitors.

Key Dates

DateDescription
12/30/2025Effective date of 1-for-16 reverse stock split by Adicet Bio, Inc.
01/24/2026Date of transaction where shares were withheld for tax obligations.
01/27/2026Date the Form 4 was signed by the attorney-in-fact.

Keywords

Adicet Bio, ACET, Schor Chen, Form 4, Insider Transaction, Tax Withholding, Restricted Stock Units, Reverse Stock Split, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.